Results - Announcements
Dr Lal Pathlabs Ltd share price gained 2.18% to Rs 1928.7 after the company's net profit registered a growth of 13.72% to Rs 193.9 crore, while revenue from operations improved marginally 9.55% to Rs 873.9 crore in Q3FY26 over Q2FY26.
The market capitalization of Healthcare Service Provider industry group stocks on BSE stood at Rs 82461.7 crore, heading higher 10.58%. It has improved by 0.55% over last one week and dipped slightly by 2% in last one month while the market capitalization of Dr Lal Pathlabs Ltd has inched up 0.41% and 0.20% in the same period respectively.
Profit before tax (PBT) of Dr Lal Pathlabs Ltd stood at Rs 260.5 crore in Q3 FY26, surging by 27.95% year-on-year, and climbing 13.90% quarter-on-quarter. EBITDA came in at Rs 246 crore, expanding by 23.38% YoY and advancing by 14.05% sequentially.
Total expenses grew marginally by 7.74% to Rs 640.6 crore in Q3FY26 over Q3FY25. During the quarter, cost of materials consumed stood at Rs 161.9 crore, posting a minor increase of 6.72% YoY, while employee benefits expense was at Rs 138.6 crore, easing 4.45% YoY.
For the TTM ended FY26, revenue from operations improved 12.25% to Rs 2762.9 crore, while net profit grew slightly 3.58% to Rs 509.8 crore, compared to previous TTM. EBITDA witnessed a strong improvement of 62100% to Rs 681.2 crore, and PBT saw a minor gain of 7.11% to Rs 669.1 crore compared to previous TTM.
The company's consolidated net cash flow from operating activities stood at Rs 635.7 crore in FY26, as against Rs 568.8 crore in FY25.
Dr Lal Pathlabs Ltd jumped 18.63% in last one year, significantly outperforming the benchmark BSE Sensex which has slipped by 8.41% during the same period.